Injectable weight loss drugs like Ozempic and Monjaro may be added to Australia's pharmaceutical benefits scheme as early as next year. Federal Health Minister Mark Butler has confirmed the government is considering subsidising these GLP-1 medications for weight loss, which could make them significantly cheaper for thousands of Australians. Currently, around half a million Australians use these injections, but only those with type 2 diabetes qualify for subsidised prescriptions.
See omnystudio.com/listener for privacy information.
Published on 18 hours ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate